Literature DB >> 3081445

Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.

R Turcotte, D Legault.   

Abstract

Mice were infected intravenously with 1.0 mg of Mycobacterium bovis BCG. At various times thereafter, spleen and peripheral lymph node cells were stimulated with concanavalin A for 18 to 20 h, and their capacity to produce interleukin-2 (IL-2) was evaluated by means of a T-cell blast proliferation technique. A depression of IL-2 production that was complete in the spleen but partial in lymph node cell cultures occurred at 2 to 3 weeks and persisted till weeks 8 to 10 after infection. No direct evidence was found for an active suppressor mechanism depressing in vitro the production of IL-2. In spleen cell cultures the suppression of IL-2 production would result from a functional defect of the IL-2-producing T-cell subset, whereas in lymph node cell cultures the depression mainly results from a relative lack of IL-2-producing cells caused by an accumulation of immunoglobulin-positive and "null" cells. Spleen cells from BCG-infected mice maintained their capacity to acquire IL-2 receptors when activated by concanavalin A.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081445      PMCID: PMC260972          DOI: 10.1128/iai.51.3.826-831.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.

Authors:  G R Klimpel; M Okada; C S Henney
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

2.  Suppressor T-cells in BCG-infected mice.

Authors:  F M Collins; S R Watson
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

3.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

5.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

7.  Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.

Authors:  B M Stadler; S F Dougherty; J J Farrar; J J Oppenheim
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. I. Effect of BCG on the frequency of cytotoxic T lymphocyte precursors and on the production of helper factors.

Authors:  L Kendall; E Sabbadini
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

Review 9.  Interleukin 2: a class of T cell growth factors.

Authors:  J Watson; D Mochizuki
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

10.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

View more
  8 in total

1.  Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed.

Authors:  E S Miller; I M Orme
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

2.  Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.

Authors:  D N McMurray; C L Mintzer; R A Bartow; R L Parr
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  A suppressor B lymphocyte inhibiting IL-2 consumption in spleen cell cultures from Mycobacterium bovis BCG-infected mice.

Authors:  R Turcotte
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

Review 4.  Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice.

Authors:  E Buschman; A S Apt; B V Nickonenko; A M Moroz; M H Averbakh; E Skamene
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Studies of depressed interleukin-2 production by spleen cells from mice following infection with cytomegalovirus.

Authors:  S Blackett; C A Mims
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.

Authors:  H Tomioka; W W Maw; K Sato; H Saito
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Unresponsiveness to Con A in spleen cell cultures of M. lepraemurium-infected mice is dependent on a defective expression of high-affinity IL-2 receptors rather than on a lack of IL-2 production.

Authors:  R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.

Authors:  Michel Denis; D Neil Wedlock; Allison R McCarthy; Natalie A Parlane; Paul J Cockle; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2007-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.